Science Explorer Back to mapMap

Most cited papers from STC Biologics (United States)

What are the most cited papers from STC Biologics (United States)?

The most cited paper from STC Biologics (United States) is "Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis" (Travis B. Nielsen, Paul Pantapalangkoor, Brian M Luna et al., 2017), with 96 citations. Next come "Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier" (2) and "B cell responses in older adults with latent tuberculosis: Considerations for vaccine development" (2).

Showing 11 of 11 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis Travis B. Nielsen, Paul Pantapalangkoor, Brian M Luna et al. · The Journal of Infectious Diseases Open access 30 Jun 2017 96
2 Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier Renuka Raman, Ben Horst, Zahra Shahrokh et al. · Molecular Genetics and Metabolism Open access 16 Jan 2026 2
3 B cell responses in older adults with latent tuberculosis: Considerations for vaccine development Sina Helbig, Sergey Rekhtman, Kristen Dostie et al. · Global Vaccines and Immunology Open access 2016 2
4 Development of analytical methods for detection of anti-drug antibodies neutralizing IL-15 and TGF-β RII activity Gilles M. Leclerc, Jack O. Egan, Lijing You et al. · Journal of Immunoassay and Immunochemistry 7 Aug 2025 1
5 Development of an Enzyme Replacement Therapy to treat CLN1 Batten disease: From Bench to Bedside Renuka Raman, Ben Horst, Maryam Zare et al. · Neurotherapeutics Open access Jul 2026 0
6 Intracerebroventricular repeat dose CPI-601 recombinant human palmitoyl-protein thioesterase-1 in cynomolgus monkey: safety, pharmacokinetics, and dose selection Renuka Raman, Jason Winsor, Kendall C. Case et al. · Molecular Genetics and Metabolism 22 Aug 2026 0
7 Enhancing HIV-1-specific CAR-T cell functional activity by treatment with a novel cytokine-based scaffold with IL-15 superagonist and TGF-β-neutralizing activity Sara Lamcaj, Erin Cole, Christopher Hiner et al. · Journal of Virology Open access 14 Aug 2026 0
8 Generation of HIV- and CD19-Specific TSCM CAR-T Cells by a Novel Cytokine-Based Scaffold 2319 Erin L. Cole, Sara Lamcaj, Agnes V. Sydenstricker et al. · The Journal of Immunology Open access Nov 2025 0
9 A humanized IL-2 fusion protein enhances T regulatory cells in vivo and restrains disease in a murine model of Alopecia Areata 4760 Maddison M. Lensing, Samuel J. Connell, Hing C. Wong et al. · The Journal of Immunology Open access Nov 2025 0
10 Natural killer cell TGF-β signaling regulates senolytic activity and vascular patterning in the postnatal lung Declan J. Gainer, Kassandra M. Coyle, Matthew T. Rätsep et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 4 Sep 2025 0
11 Pre-clinical development of an enzyme replacement therapy (CPI-601) for CLN1 Batten disease: process development, stability and uptake studies in different species Renuka Raman, Ben Horst, Maryam Zare et al. · Neurotherapeutics Open access Jul 2025 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.